Literature DB >> 9268203

Rapid elimination of a high-titered F VIII inhibitor by high dose recombinant F VIII combined with high dose immunoglobulin infusion.

C Mauz-Korholz, D Korholz, U Gobel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9268203

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

Review 1.  Experience of Immune Tolerance Induction Therapy for Hemophilia A Patients with Inhibitors from a Single Center in India.

Authors:  Tulika Seth
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-04       Impact factor: 0.900

Review 2.  Current options and new developments in the treatment of haemophilia.

Authors:  Trisha Wong; Michael Recht
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

3.  Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report.

Authors:  Peter Kubisz; Ivana Plamenova; Pavol Holly; Jan Stasko
Journal:  J Med Case Rep       Date:  2012-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.